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Discovering NF-kB
David Baltimore
California Institute of Technology, Pasadena, California 91125
Correspondence: baltimo@caltech.edu
NF-kB is a protein transcription factor thatcan orchestrate complex biological pro-
cesses, such as the inflammatory response.
It was discovered in a very different and very
limited context, and only over time has its
protean nature become evident.
It was actually a very logical process that led
us to NF-kB. Although the discovery was very
exciting, NF-kB was not the protein we were
seeking at the time. To explain this, I must go
back to when my laboratory first became
interested in immunology.
My first independent positionwas at the Salk
Institute, where I arrived in the spring of 1965.
For the previous 4 years that I had been in
research, my interests had revolved around the
biochemistry of viruses. At Salk, although my
work continued to be on viruses, I was exposed
to the fascinating questions of immunology.
The main issue was how the enormous diversity
of antibodies is generated froma limited amount
of genetic information. Like so many others, I
thought about the question, but it took the
experimental attention of Susumu Tonegawa,
in 1976, to crack the problem and show that
the solution involved DNA rearrangement.
In 1974, the methods of recombinant DNA
technology were first developed and it was clear
that previously intractable complex systems,
like the immune system, could be examined
with these methods. In 1976, knowing that the
methods were available and that the paradigm
of DNA rearrangement had been established,
some postdoctoral students in my laboratory
and I decided to plunge into this field. I
wanted to apply our biochemical skills to this
suddenly tractable system. We were already
working on one enzyme that was involved in
immunoglobulin gene specification, terminal
transferase, and had a useful viral transform-
ation system in the laboratory that affected
lymphoid cells, the Abelson mouse leukemia
virus. So, immunologywasnot totally new tous.
We had to develop our skills with recombi-
nant DNA methods, become familiar with the
awful lingo of immunology, and define some
questions for ourselves, but all of that came
to pass. In time, I began to see the question
of how immune cells develop as the key one
for my laboratory. It seemed likely that the
problem would come down to understanding
the control of transcription factors. So, we
focused on transcription of immune cell genes
as our primary interest. We had produced
evidence that in the development of B lym-
phocytes, the heavy-chain locus is first to
rearrange its DNA, followed by the light-chain
locus (Siden et al. 1981). Cary Queen joined
the laboratory and studied the transcription
of the k light-chain gene and demonstrated
that it contains an intragenic transcriptional
enhancer (Queen and Baltimore 1983). These
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developments led us to ask whether it might be
possible to understand the transition of a cell
from heavy-chain only to heavy-plus-light
chain by understanding the transcription
factors that bind to the k light-chain enhancer.
Understanding the proteins that bind to the
regulatory sites in both the heavy- and the
light-chain genes became the project of a new
postdoctorate, Ranjan Sen. He worked closely
with people in Phil Sharp’s laboratory, who
had similar interests.
Ranjan andHarinder Singh, from the Sharp
laboratory, worked out how to usemobility shift
assays to find transcription factors, and first
published on the existence of the Oct factors
(Singh et al. 1986). Then Ranjan applied the
methods to enhancers and found multiple
factors binding to both the heavy- and k light-
chain enhancers (Sen and Baltimore 1986a).
Among the factors he discovered was one that
bound only to the k light-chain enhancer—it
covered the sequence GGGACTTTCC. We
called it NF-kB because it was a nuclear factor
that bound selectively to the k enhancer and
was found in extracts of B-cell tumors but not
other cell lines (Sen and Baltimore 1986a).
The next step was supposed to be the killer
experiment. 70Z/3 cells were known to have a
rearranged k light chain but not to express it
and did not have detectable NF-kB. We knew
also that treatment of the cells with lipopoly-
saccharide (LPS) induced transcription of
the k gene. The killer result would be that
LPS induced NF-kB. Sure enough, it did (Sen
and Baltimore 1986b). Furthermore, it did so
without the need for new protein synthesis.
Thus, we concluded that NF-kB is a factor that
pre-exists in an apparently inhibited state and is
released from that inhibition by LPS treatment.
It looked like we had found a factor that might
cause cells to go from making only heavy chain
to making heavy and light chains, which could
thus explain a step in differentiation. However,
history has treated this optimistic conclusion
with total disrespect, as is shown below.
I will not describe all that we have done on
the NF-kB system but will only take this story
one step further. That step was taken by
Patrick Baeuerle, who joined my laboratory as
a postdoctoral fellow. He found that the inactive
form of NF-kB is in the cytoplasm of 70Z/3
cells and can be liberated from its inhibited
form by treatment of cytoplasmic extracts with
a detergent (Baeuerle and Baltimore 1988a).
This discovery allowed us to purify the inhi-
bitor, which we named IkB (Baeuerle and
Baltimore 1988b). That set the stage for a
detailed biochemical study of the activation
process, an effort that has involved many inves-
tigators and is not complete to this day.
The seeds of doubt about the role of NF-kB
as a regulator of B-cell development were sown
in these early papers. We showed that the inhib-
ited NF-kB is not specific to B-lineage cells:
it was evident in T cells and even HeLa cells
(Sen and Baltimore 1988b)—we know now
that virtually all cells have it. Another paper
showed this even more directly (Baeuerle and
Baltimore 1988a). Thus, it was evident that
NF-kB could be active in a wide range of cells
and further work has borne this out.
A later postdoctorate, Yang Xu, provided
the coup de grace for the notion that NF-kB is
critical to k-chain transcription. He knocked
out the intronic k enhancer—containing the
NF-kB binding site—in mice and showed
that, in those cells that rearrange k, the gene is
transcribed at a normal rate (Xu et al. 1996).
There is a second enhancer, lacking an NF-kB
binding site, that can control k gene transcrip-
tion. Each enhancer plays a quantitative role
in k-gene rearrangement, but not a qualitative
one (Inlay et al. 2002).
Meanwhile, over the 24 years since its dis-
covery, NF-kB has been implicated in a wide
range of normal and disease processes. No
transcription factor has attracted more experi-
mental attention. Its role in inflammatory
processes is especially important. Yet, its role
in the transcription of the k light chain, for
which it was named, remains uncertain.
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